https://ospreymed.com/wp-content/uploads/2017/06/tpr-dyevert.jpg
600
800
Rob Coleman
/wp-content/uploads/2017/04/osprey-logo-224w.png
Rob Coleman2017-06-08 12:00:402017-07-05 20:31:19Cutting Down on Dye May Make Heart Procedures Safer for Kidney PatientsOsprey Medical is
dedicated to making
angiography safer
for chronic kidney
disease patients.
Osprey Medical designs, develops, and manufactures proprietary devices and monitoring systems that reduce the amount of X-ray dye (contrast) used during commonly performed heart imaging procedures.
Our Mission
To improve outcomes in patients suffering from Chronic Kidney Disease (CKD) by reducing contrast induced Acute Kidney Injury (AKI) and lowering hospital costs.
238%
Year over year revenue growth*
296%
Year over year unit growth*
462%
Year over year new hospitals purchasing*
*FY ’15 to FY ’16
https://ospreymed.com/wp-content/uploads/2017/06/tpr-dyevert.jpg
600
800
Rob Coleman
/wp-content/uploads/2017/04/osprey-logo-224w.png
Rob Coleman2017-06-08 12:00:402017-07-05 20:31:19Cutting Down on Dye May Make Heart Procedures Safer for Kidney Patients
https://ospreymed.com/wp-content/uploads/2017/04/DyeVert-PLUS-System.jpg
733
813
Rob Coleman
/wp-content/uploads/2017/04/osprey-logo-224w.png
Rob Coleman2017-03-09 01:40:312017-07-05 20:13:10Osprey Medical Receives US FDA Clearance for DyeVert™ PlusOsprey Medical’s product specific labeling indications may vary by geography.